Serafin Andrew 4
4 · Harmony Biosciences Holdings, Inc. · Filed Jan 26, 2024
Insider Transaction Report
Form 4
Serafin Andrew
CHIEF STRATEGY OFFICER
Transactions
- Award
Stock Option
2024-01-24+47,750→ 47,750 totalExercise: $30.69Exp: 2034-01-24→ Common Stock (47,750 underlying) - Award
Restricted Stock Unit
2024-01-24+10,000→ 10,000 total→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.